1. Home
  2. KPRX vs JXG Comparison

KPRX vs JXG Comparison

Compare KPRX & JXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

HOLD

Current Price

$2.54

Market Cap

8.0M

Sector

Health Care

ML Signal

HOLD

Logo JX Luxventure Limited

JXG

JX Luxventure Limited

HOLD

Current Price

$4.01

Market Cap

7.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPRX
JXG
Founded
1998
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0M
7.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KPRX
JXG
Price
$2.54
$4.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
617.6K
2.5K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.77
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$0.23
52 Week High
$4.18
$10.29

Technical Indicators

Market Signals
Indicator
KPRX
JXG
Relative Strength Index (RSI) 62.75 54.21
Support Level $1.90 $3.70
Resistance Level $2.94 $4.39
Average True Range (ATR) 0.21 0.12
MACD 0.05 0.04
Stochastic Oscillator 65.79 72.86

Price Performance

Historical Comparison
KPRX
JXG

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About JXG JX Luxventure Limited

JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.

Share on Social Networks: